An Open-Label, Multicenter Study to Evaluate the Safety/Tolerability and Clinical Utility of Low-Dose TTS-Fentanyl D-TRANS in Taiwan Patients With Cancer Pain.
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2014
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions
- Sponsors Johnson & Johnson
- 01 Jul 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual initiation date (Oct 2008) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.